Menu
Minovia is a clinical-stage biotechnology company, developing novel therapies to fight mitochondrial diseases, as well as biomarkers to identify mitochondrial dysfunction.
Our vision in the LiquidBx consortium is to correlate mitochondrial biomarkers with other disease-associated biomarkers, especially in Alzheimer Disease. Expand our protfolio of collaborators and utilize our mitochondrial biomarkers for understanding different disease pathologies.
Convert our existing analytical methods, developed to qualify our mitochondrial products, to blood biomarkers. Generate mitochondrial data from patient samples that can be correlated with other blood biomarkers and disease severity.
Copyright 2023 LIQUIDBXÂ – All Rights Reserved
Produced by Webzilla